Consensus on the need for a hierarchical list of patient-reported pain outcomes for metaanalyses of knee osteoarthritis trials: An OMERACT objective

Journal of Rheumatology

Volumn 42, Issue 10, 2015, Pages 1971-1975

  Christensen, Robin ^a   Maxwell, Lara J ^b   Jüni, Peter ^c,d   Tovey, David ^e   Williamson, Paula R ^f   Boers, Maarten ^g   Goel, Niti ^h,i   Buchbinder, Rachelle ^j,k   March, Lyn ^l   Terwee, Caroline B ^g   Singh, Jasvinder A ^m,n   Tugwell, Peter ^b  

^a Mental Health Services CPH   (Denmark)

^b UNIVERSITY OF OTTAWA   (Canada)

^c Institute of Social and Preventive Medicine   (United States)

^d UNIVERSITY OF BERN   (Switzerland)

^e Cochrane Collaboration ^*  (Switzerland)

^f UNIVERSITY OF LIVERPOOL   (United Kingdom)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ Patient Research Partner   (Netherlands)

^j MONASH UNIVERSITY   (Australia)

^k CABRINI INSTITUTE   (Australia)

^l UNIVERSITY OF SYDNEY   (Australia)

^m BIRMINGHAM VA MEDICAL CENTER   (United States)

ⁿ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

more..

Author keywords

Cochrane Collaboration; Metaanalysis; OMERACT; Osteoarthritis; Pain; Patient outcome assessment

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); CONSENSUS; HUMAN; KNEE OSTEOARTHRITIS; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PAIN ASSESSMENT; PAIN INTENSITY; PRIORITY JOURNAL; PSYCHOMETRY; SAMPLE SIZE; SELECTION BIAS; VISUAL ANALOG SCALE; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX;

EID: 84943329508     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.141384     Document Type: Article

References (34)

1. Boers M, Idzerda L, Kirwan JR, Beaton D, Escorpizo R, Boonen A, et al. Toward a generalized framework of core measurement areas in clinical trials: a position paper for OMERACT 11. J Rheumatol 2014;41:978-85.
2. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29:1039-49.
3. Bliddal H, Christensen R. The treatment and prevention of knee osteoarthritis: a tool for clinical decision-making. Expert Opin Pharmacother 2009;10:1793-804.
4. Bellamy N, Kirwan J, Boers M, Brooks P, Strand V, Tugwell P, et al. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol 1997;24:799-802.
5. Garratt AM, Brealey S, Gillespie WJ. Patient-assessed health instruments for the knee: a structured review. Rheumatology 2004;43:1414-23.
6. Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010;18:476-99.
7. Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res 2012;64:455-74.
8. McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage 2014;22:363-88.
9. Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 2011;64:395-400.
10. Ghogomu EA, Maxwell LJ, Buchbinder R, Rader T, Pardo PJ, Johnston RV, et al. Updated method guidelines for Cochrane Musculoskeletal Group systematic reviews and metaanalyses. J Rheumatol 2014;41:194-205.
11. Dickersin K, Rennie D. Registering clinical trials. JAMA 2003;290:516-23.
12. Dwan K, Altman DG, Clarke M, Gamble C, Higgins JP, Sterne JA, et al. Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials. PLoS Med 2014;11:e1001666.
13. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004;291:2457-65.
14. Riveros C, Dechartres A, Perrodeau E, Haneef R, Boutron I, Ravaud P. Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals. PLoS Med 2013;10:e1001566.
15. Copas J, Dwan K, Kirkham J, Williamson P. A model-based correction for outcome reporting bias in meta-analysis. Biostatistics 2014;15:370-83.
16. Booth A, Clarke M, Ghersi D, Moher D, Petticrew M, Stewart L. An international registry of systematic-review protocols. Lancet 2011;377:108-9.
17. Booth A, Clarke M, Dooley G, Ghersi D, Moher D, Petticrew M, et al. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev 2012;1:2.
18. Booth A, Clarke M, Dooley G, Ghersi D, Moher D, Petticrew M, et al. PROSPERO at one year: an evaluation of its utility. Syst Rev 2013;2:4.
19. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009;62:e1-34.
20. Boers M, Kirwan JR, Wells G, Beaton D, Gossec L, D'Agostino MA, et al. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. J Clin Epidemiol 2014;67:745-53.
21. Tendal B, Nuesch E, Higgins JP, Juni P, Gotzsche PC. Multiplicity of data in trial reports and the reliability of meta-analyses: empirical study. BMJ 2011;343:d4829.
22. Dwan K, Gamble C, Williamson PR, Kirkham JJ. Systematic review of the empirical evidence of study publication bias and outcome reporting bias-an updated review. PLoS One 2013;8:e66844.
23. Gagnier JJ, Morgenstern H, Altman DG, Berlin J, Chang S, McCulloch P, et al. Consensus-based recommendations for investigating clinical heterogeneity in systematic reviews. BMC Med Res Methodol 2013;13:106.
24. Terwee CB, Mokkink LB, Knol DL, Ostelo RW, Bouter LM, de Vet HC. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res 2012;21:651-7.
25. Huskisson EC. Measurement of pain. J Rheumatol 1982;9:768-9.
26. Jüni P, Reichenbach S, Dieppe P. Osteoarthritis: rational approach to treating the individual. Best Pract Res Clin Rheumatol 2006; 20:721-40.
27. Juhl C, Lund H, Roos EM, Zhang W, Christensen R. A hierarchy of patient-reported outcomes for meta-analysis of knee osteoarthritis trials: empirical evidence from a survey of high impact journals. Arthritis 2012;2012:136245.
28. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833-40.
29. Roos EM, Roos HP, Lohmander LS, Ekdahl C, Beynnon BD. Knee Injury and Osteoarthritis Outcome Score (KOOS)-development of a self-administered outcome measure. J Orthop Sports Phys Ther 1998;28:88-96.
30. Roos EM, Toksvig-Larsen S. Knee injury and Osteoarthritis Outcome Score (KOOS)-validation and comparison to the WOMAC in total knee replacement. Health Qual Life Outcomes 2003;1:17.
31. Dechartres A, Altman DG, Trinquart L, Boutron I, Ravaud P. Association between analytic strategy and estimates of treatment outcomes in meta-analyses. JAMA 2014;312:623-30.
32. Sterne JA, Juni P, Schulz KF, Altman DG, Bartlett C, Egger M. Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research. Stat Med 2002;21:1513-24.
33. Hansen JB, Juhl CB, Boutron I, Tugwell P, Ghogomu EA, Pardo PJ, et al. Assessing bias in osteoarthritis trials included in Cochrane reviews: protocol for a meta-epidemiological study. BMJ Open 2014;4:e005491.
34. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 2010;63:737-45.